Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus

Background Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. Methods Serological identification of antigens through recombinant cDNA expr...

Full description

Saved in:

Bibliographic Details
Published in:	BMC endocrine disorders Vol. 23; no. 1; pp. 1 - 239
Main Authors:	Namiki, Toshiki, Takemoto, Minoru, Hayashi, Aiko, Yamagata, Hiroki, Ishikawa, Takahiro, Yokote, Koutaro, Li, Shu-Yang, Kubota, Masaaki, Zhang, Bo-Shi, Yoshida, Yoichi, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Kobayashi, Yoshio, Terada, Jiro, Naito, Akira, Tatsumi, Koichiro, Takizawa, Hirotaka, Nakamura, Rika, Kuroda, Hideyuki, Iwadate, Yasuo, Hiwasa, Takaki
Format:	Journal Article
Language:	English
Published:	London BioMed Central Ltd 30-10-2023 BioMed Central BMC
Subjects:	Angina pectoris Antibodies Antibody biomarker Antigens Apnea Arteriosclerosis Atherosclerosis Autoantibodies Autoimmune diseases Autoimmunity Blood pressure Cardiovascular disease Cardiovascular diseases Care and treatment Chromatography Development and progression Diabetes Diabetes mellitus Diabetics Disease Heart attacks Hospitals Immunoglobulin G Ischemia Medical research Medicine, Experimental Patients Phosphoenolpyruvate carboxykinase 1 Prognosis Proteins Serology Sleep apnea syndromes Sleep disorders Stroke Stroke (Disease) Survival Transient ischemic attack Taiwan La Jolla California United States > US Japan
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!